Drawing for AFSTYLA GOPANION

USPTO serial 87574965

AFSTYLA GOPANION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
KOLODNER, LOUIS FRANCIS
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AFSTYLA GOPANION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals for the treatment or prevention of blood and/or bleeding disorders; Blood products, namely, a pharmaceutical preparation blood clotting aid and delivery system for use in human and veterinary medicine; Blood proteins for therapeutic use, namely, blood proteins for therapeutic use for medical purposes; Pharmaceutical blood products derived from recombinant DNA technology, namely, blood for medical purposes; Blood products, namely, pharmaceutical preparations for blood disorders, diseases or conditionsACTIVE
009Computer software for controlling and managing patient medical information, downloadable mobile software applications for controlling and managing patient medical informationACTIVE
010Medical apparatus and instruments, namely, intravenous administration instruments for medical purposes; Injection devices for pharmaceuticals; Medical apparatus and instruments, namely, medical instruments for subcutaneous therapyACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 3, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 3, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 1, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 31, 2020EX5GSOU EXTENSION 5 GRANTED
Aug 31, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 21, 2020EXT5SOU EXTENSION 5 FILED
Aug 21, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 29, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2020EX4GSOU EXTENSION 4 GRANTED
Feb 27, 2020EXT4SOU EXTENSION 4 FILED
Feb 27, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 30, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2019EX3GSOU EXTENSION 3 GRANTED
Aug 28, 2019EXT3SOU EXTENSION 3 FILED
Aug 28, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 12, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 8, 2019EX2GSOU EXTENSION 2 GRANTED
Mar 8, 2019EXT2SOU EXTENSION 2 FILED
Mar 8, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 30, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 28, 2018EX1GSOU EXTENSION 1 GRANTED
Aug 28, 2018EXT1SOU EXTENSION 1 FILED
Aug 28, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 27, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 30, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 30, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 10, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 15, 2017ALIEASSIGNED TO LIE
Nov 30, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 29, 2017XAECEXAMINER'S AMENDMENT ENTERED
Nov 29, 2017GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 29, 2017GNEAEXAMINERS AMENDMENT E-MAILED
Nov 29, 2017CNEAEXAMINERS AMENDMENT -WRITTEN
Nov 22, 2017DOCKASSIGNED TO EXAMINER
Aug 24, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 22, 2017NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance